- Preclinical evaluation of [
Preclinical evaluation of [
Contrast media & molecular imaging (2016-08-26)
Christel Vangestel, David Thomae, Jeroen Van Soom, Johan Ides, Leonie Wyffels, Patrick Pauwels, Sigrid Stroobants, Pieter Van der Veken, Viktor Magdolen, Jurgen Joossens, Koen Augustyns, Steven Staelens
PMID27558262
RÉSUMÉ
Urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 are key players in cancer invasion and metastasis. Both uPA and PAI-1 have been described as prognostic biomarkers; however, non-invasive methods measuring uPA activity are lacking. We developed an indium-111 (
MATÉRIAUX
Référence du produit
Marque
Description du produit
Sigma-Aldrich
Human PLAU / Urokinase-type Plasminogen Activator ELISA Kit, for serum, plasma, cell culture supernatants and urine